Quantcast

Reportlinker Adds Regenerative Medicine – Global Market Trends

November 25, 2009

NEW YORK, Nov. 25 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:

Regenerative Medicine – Global Market Trends

http://www.reportlinker.com/p0164236/Regenerative-Medicine—Global-Market-Trends.html

Science of regeneration offers huge opportunities for the betterment of mankind. Regenerative medicine offers therapeutic opportunities where there are presently no treatments. The regenerative medicine industry is in nascent stages in terms of commercial applications. To date, most of the advances made in regenerative medicine are confined to bone and joint applications, and to an extent regeneration of blood. Even in bone and joint applications the advances are limited to in-vitro development. Huge opportunity for regenerative medicine exists in in-vivo development. It would not be long before regenerative therapies for chronic conditions such as diabetes are realized.

These and other market data and trends are presented in “Regenerative Medicine: Global Market Trends” by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

REGENERATIVE MEDICINE BMR-1036

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. INDUSTRY OVERVIEW 4

Regenerative Medicine – the Past, the Present, & the Future 4

Another Revolution in the Making? 5

Conventional Chemical Medicine Vs Regenerative Medicine 6

The Need for Regenerative Medicine 6

Regenerative Medicine Throws in Several New Therapies 7

What’s in Store? 7

Regenerative Medicine to Arrest Ageing? 7

Thriving on an Aging World Population 8

Faster Healing Process 8

Regenerative Medicine to Overcome Donor Organs Shortage 8

Possible Scenarios 9

Stem Cell Research – Not Just Another Medical Advancement 9

Key Issues at Play 10

Market Potential 10

Regenerative Medicine in Bone and Joint Applications 10

US Corners a Lion’s Share 10

Growth Drivers 11

Trends & Issues 11

Biomaterials Sought After in Regenerative Medicine 11

Upbeat Market for Cell-based Tissue Engineering 12

Progenitor Cell Therapy to Witness No Holds Barred Growth 12

Players Embrace Automation in Production Facilities 13

Contract Manufacturing, a Growing Sector 13

Investors Wary of Funding Regenerative Medicine 14

Regenerative Medicine Field Lags Behind due to Segregated Focus 14

Challenges to Be Encountered by Tissue Engineering Companies 15

Activity in the Field of Regenerative Medicine 15

3. PRODUCTS FACTS 16

4. REGULATORY ENVIRONMENT 17

Regulatory Norms Governing ES Cell Research 17

Legality of ES Cell Use in Major Developed Nations 17

5. CORPORATE DEVELOPMENTS 17

Cytori and Green Hospital Supply Ink Strategic Equity Deal 17

RNL Bio Establishes Research Unit at Newcastle University 18

Tengion Begins Third Phase II Clinical Trial of Neo-Bladder

Augment(TM) 18

Organogenesis Signs MoU with NTEC 18

BioTime Establishes New Stem Cell Division 19

Integra Life Sciences Acquires IsoTis, Inc. 19

NovaThera and Gamida Join Hands for Developing Cell

Therapeutics for Lung- Regeneration 20

Tigenix Teams Up with Fidea to Develop Biological Joint Implants 20

Scotland Plans to Build Center for Regenerative Medicine in

Edinburgh 21

Celprogen Launches 11 Cancer Stem Cells 21

6. MAJOR PLAYERS 21

BioVest International, Inc. (US) 21

Curis, Inc. (US) 21

Cytori Therapeutics, Inc. (US) 22

DeveloGen AG (Germany) 22

Forticell Bioscience, Inc. (US) 22

Geron Corporation (US) 22

Human Genome Sciences, Inc. (US) 23

IsoTis, Inc. 23

Kiadis Pharma B.V. 23

LifeCell Corporation (US) 23

Osiris Therapeutics, Inc. (US) 23

Tepha Inc. (US) 24

TiGenix N.V. (Belgium) 24

7. GLOBAL MARKET ANALYTICS 25

8. THE UNITED STATES 25

Regenerative Medicine in Bone and Joint Applications 25

Regenerative Therapy – Best Fit for Joint Problems 26

Millions of American Patients Put their Hope in Stem Cell

Research 27

US Witnesses Mixed Response for Government Support for hESC

Research 27

CBI’s Human Tissue Products for Treating Liver Failure and

Diabetes 28

Market for Liver and Pancreas Transplantation 29

Implantable Regenerative Products Take Over Sports Medicine 29

9. JAPAN 30

Research Activity in Regenerative Medicine Field 30

More Companies Eye the Regenerative Medicine Potential 31

Competition Heats up Behind Closed Doors 31

Japanese Firms Need to Catch Up with US and European Competitors 32

Science Ministry Rolls Out Regenerative Medicine Project 32

Regenerative Medicine Exempted from Ban on Human Cloning 32

10. EUROPE 33

11. REVIEW OF REGENERATIVE MEDICINE IN OTHER GEOGRAPHIC MARKETS 34

a. Canada 34

University of Toronto – Spearheading Regenerative Medicine

Research 34

b. Asia-Pacific 35

China 35

Substantial Government Support 35

India 35

CSIR- Leading the way in Regenerative Medicine Research 35

High Growth Opportunities 35

South Korea 36

Malaysia 36

Singapore 36

c. Rest of World 37

Argentina 37

South Africa 38

EXHIBITS

Table 1: Global Market for Regenerative Medicine Products in

Bone and Joint Applications by Region for the Period 2007-2015

(Sales in US$ Million)

Table 2: Percentage Breakdown of Global Market for

Regenerative Medicine Products for Bone and Joint Applications

by Region for the Years 2008 & 2012

Table 3: Prevalence of Various Diseases in the US

Table 4: The US Market for Regenerative Medicine Products in

Bone and Joint Applications Market: 2007-2015 (Sales in US$

Million)

Table 5: Japanese Market for Regenerative Medicine Products in

Bone and Joint Applications Market: 2007-2015 (Sales in US$

Million)

Table 6: European Market for Regenerative Medicine Products in

Bone and Joint Applications Market: 2007-2015 (Sales in US$

Million)

COMPANIES PROFILED

To order this report:

Therapy Industry: Regenerative Medicine – Global Market Trends

More Market Research Report


Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker


Source: newswire



comments powered by Disqus